http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2540911-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56c13ce337340fd50f39562868ca87c2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
| filingDate | 2013-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3805cec902eb1384be977d307e344561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5da7d437fd39f37d109a40d427284bdb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aa4e5c21cb6ec47ee36d9c49580ae5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e978ee57e9bb245d2119ce778a8b6c06 |
| publicationDate | 2015-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2540911-C2 |
| titleOfInvention | Method for correction of night eating syndrome in patients with anxiety and depressive disorders |
| abstract | FIELD: medicine. n SUBSTANCE: correcting night eating syndrome in the patients with anxiety and depressive disorders is ensured by prescribing agomelatine 25mg a day for the night. The therapeutic course is continued until a long-lasting remission is observed for 6 months and more. n EFFECT: method enables reducing the intensity of night eating syndrome in the patients with an affective pathology by levelling the anxiety and depressive manifestations with improving the sleep quality and minimum side effects. n 2 tbl, 2 ex |
| priorityDate | 2013-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.